Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4

被引:120
|
作者
Kretschmer, A [1 ]
Moepert, K [1 ]
Dames, S [1 ]
Sternberger, M [1 ]
Kaufmann, J [1 ]
Klippel, A [1 ]
机构
[1] Atugen AG, D-13125 Berlin, Germany
关键词
Smad; TGF-beta; tumor suppressor; microarray;
D O I
10.1038/sj.onc.1206791
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Smad transcription factors mediate the growth inhibitory effect of transforming growth factor-beta (TGF-beta) in many cell types. Mutational inactivation of Smads has been correlated with loss of responsiveness to TGF-beta-mediated signal transduction. In this study, we compare the contribution of individual Smads to TGF-beta-induced growth inhibition and endogenous gene expression in isogenic cellular backgrounds. Smad2, Smad3 and Smad4 expression were selectively inhibited in differentiation-competent cells by using improved antisense molecules. We found that TGF-beta mediates its inhibitory effect on HaCaT keratinocyte cell growth predominantly through Smad3. Inhibition of Smad3 expression was sufficient to interfere with TGF-beta-induced cell cycle arrest and to induce or suppress endogenous cell cycle regulators. Inhibition of Smad4 expression exhibited a partial effect, whereas inhibition of Smad2 expression had no effect. By gene expression pro. ling, we identified TGF-beta-dependent genes that are differentially regulated by Smad2 and Smad3 under regular growth conditions on a genome-wide scale. We show that Smad2, Smad3 and Smad4 contribute to the regulation of TGF-beta responses to varying extents, and demonstrate, in addition, that these Smads exhibit distinct roles in different cell types.
引用
收藏
页码:6748 / 6763
页数:16
相关论文
共 50 条
  • [21] Epigenetic Modulation of Class-Switch DNA Recombination to IgA by miR-146a Through Downregulation of Smad2, Smad3 and Smad4
    Casali, Paolo
    Li, Shili
    Morales, Grecia
    Daw, Cassidy C.
    Chupp, Daniel P.
    Fisher, Amanda D.
    Zan, Hong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [22] Smad2 and Smad3 coordinately regulate craniofacial and endodermal development
    Liu, Y
    Festing, M
    Thompson, JC
    Hester, M
    Rankin, S
    El-Hodiri, HM
    Zorn, AM
    Weinstein, M
    DEVELOPMENTAL BIOLOGY, 2004, 270 (02) : 411 - 426
  • [23] Smad2 and Smad4 gene mutations in hepatocellular carcinoma
    Yakicier, MC
    Irmak, MB
    Romano, A
    Kew, M
    Ozturk, M
    ONCOGENE, 1999, 18 (34) : 4879 - 4883
  • [24] Roles of Smad3 in TGF-β signaling during carcinogenesis
    Millet, Caroline
    Zhang, Ying E.
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2007, 17 (04): : 281 - 293
  • [25] Transcriptional regulation of Smad2 is required for enhancement of TGFβ/Smad signaling by TGFβ inducible early gene
    Johnsen, SA
    Subramaniam, M
    Katagiri, T
    Janknecht, R
    Spelsberg, TC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 87 (02) : 233 - 241
  • [26] The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma
    Cho, Soo Youn
    Ha, Sang Yun
    Huang, Song-Mei
    Kim, Jeong Hoon
    Kang, Myung Soo
    Yoo, Hae-yong
    Kim, Hyeon-ho
    Park, Cheol-Keun
    Um, Sung-Hee
    Kim, Kyung-Hee
    Kim, Seok-Hyung
    MEDICAL ONCOLOGY, 2014, 31 (11) : 1 - 9
  • [27] Developmentally Regulated SMAD2 and SMAD3 Utilization Directs Activin Signaling Outcomes
    Itman, Catherine
    Small, Chris
    Griswold, Michael
    Nagaraja, Ankur K.
    Matzuk, Martin M.
    Brown, Chester W.
    Jans, David A.
    Loveland, Kate L.
    DEVELOPMENTAL DYNAMICS, 2009, 238 (07) : 1688 - 1700
  • [28] The regulation of TGF-β/SMAD signaling by protein deubiquitination
    Zhang, Juan
    Zhang, Xiaofei
    Xie, Feng
    Zhang, Zhengkui
    van Dam, Hans
    Zhang, Long
    Zhou, Fangfang
    PROTEIN & CELL, 2014, 5 (07) : 503 - 517
  • [29] Smad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
    Meng, Xiao Ming
    Huang, Xiao Ru
    Chung, Arthur C. K.
    Qin, Wei
    Shao, Xinli
    Igarashi, Peter
    Ju, Wenjun
    Bottinger, Erwin P.
    Lan, Hui Yao
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (09): : 1477 - 1487
  • [30] Mutation analysis of transforming growth factor β type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma
    Osawa, H
    Shitara, Y
    Shoji, H
    Mogi, A
    Kuwano, H
    Hagiwara, K
    Takenoshita, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (04) : 723 - 728